Introduction Transradial access is increasingly used among neurointerventionalists as an alternative to the transfemoral route. Currently available data, building on the interventional cardiology experience, primarily focus on right radial access. However, there are clinical scenarios when left-sided access may be indicated. The purpose of this study was to evaluate the technical feasibility of left transradial access to cerebral angiography across three institutions.
Methods A retrospective chart review was performed for patients who underwent cerebral angiography accessed via the left radial artery at three institutions between January 2018 and July 2019. The outcome variables studied were successful catheterization, vascular complications, and fluoroscopic time.
Results Nineteen patients underwent a total of 25 cerebral angiograms via left transradial access for cerebral aneurysms (n=15), basilar occlusion (n=1), carotid stenosis (n=1), arteriovenous malformation (n=1), and cervical neurofibroma (n=1). There were 12 diagnostic angiograms and 13 interventional angiograms. The left transradial approach was chosen due to left vertebrobasilar pathology (n=22), right subclavian stenosis (n=2), and previous right arm amputation (n=1). There was one instance of radial artery spasm, which resolved after catheter removal, and one conversion to transfemoral access in an interventional case due to lack of distal catheter support. There were no procedural complications.
Conclusions Left transradial access in diagnostic and interventional cerebral angiography is a technically feasible, safe, and an effective alternative when indicated, and may be preferable for situations in which pathology locations or anatomic limitations preclude right-sided radial access.
Statistics from Altmetric.com
Contributors All authors contributed to the study design, data acquisition, data interpretation and/or manuscript drafting and revision, and each provided final approval of the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.
Competing interests JWO reports grants and personal fees from MicroVention and personal fees from Terumo Medical and Microbot. MRL reports equity interest in eLoupes Inc, Cerebrotech, and Corindus, and has unrestricted educational grants from Stryker, Medtronic, and Philips Volcano. ECP is a consultant to Stryker Neurovascular, Penumbra, Medtronic Neurovascular, and Cerenovus, and a shareholder in RIST Neurovascular. MW is a consultant to Medtronic.
Patient consent for publication Not required.
Ethics approval This research was reviewed and approved by the University of Washington Institutional Review Board, Study Number 00006662.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.